Date | Return on Equity (ROE) | Return on Capital Employed (ROCE) | Interest Coverage Ratio | Debt to Equity Ratio |
---|
CEO | Ms. Wu Guiping |
IPO Date | July 19, 2017 |
Location | China |
Headquarters | 1/16 Nanjing Jiangbei New |
Employees | 1,451 |
Sector | Health Care |
Industries |
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd manufactures and sells heparin sodium and low molecular weight heparin products for pharmaceutical companies in the People's Republic of China. It offers enoxaparin sodium, dalteparin sodium, and naqu heparin calcium injections. The company also exports its products primarily to the European and American countries. The company was founded in 2000 and is based in Nanjing, the People's Republic of China.
Past 5 years
USD 5.53
USD 6.00
USD 2.14
USD 2.00
USD 3.37
StockViz Staff
January 31, 2025
Any question? Send us an email